15033673

Source:http://linkedlifedata.com/resource/pubmed/id/15033673

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0015730, umls-concept:C0016360, umls-concept:C0030705, umls-concept:C0205179, umls-concept:C0205390, umls-concept:C0246415, umls-concept:C0278996, umls-concept:C1517927, umls-concept:C1519810
pubmed:issue	4
pubmed:dateCreated	2004-3-22
pubmed:abstractText	To determine the safety profile and activity of the combination of docetaxel, cisplatin and 5-fluorouracil (5-FU) in chemotherapy-naive patients with squamous cell carcinoma of the head and neck (SCCHN).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0923-7534
pubmed:author	pubmed-author:AwadaAA, pubmed-author:CastelijnsJ AJA, pubmed-author:De MulderPP, pubmed-author:JoosensEE, pubmed-author:KaandersJJ, pubmed-author:KergerJJ, pubmed-author:Le BouderCC, pubmed-author:NguyenHH, pubmed-author:SchrijversDD, pubmed-author:Van HerpenCC, pubmed-author:Van LaerCC, pubmed-author:Van den WeyngaertDD, pubmed-author:VermorkenJ BJB
pubmed:issnType	Print
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	638-45
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:15033673-Adult, pubmed-meshheading:15033673-Aged, pubmed-meshheading:15033673-Antineoplastic Agents, pubmed-meshheading:15033673-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15033673-Cisplatin, pubmed-meshheading:15033673-Feasibility Studies, pubmed-meshheading:15033673-Female, pubmed-meshheading:15033673-Fluorouracil, pubmed-meshheading:15033673-Head and Neck Neoplasms, pubmed-meshheading:15033673-Humans, pubmed-meshheading:15033673-Male, pubmed-meshheading:15033673-Middle Aged, pubmed-meshheading:15033673-Nausea, pubmed-meshheading:15033673-Neoplasm Staging, pubmed-meshheading:15033673-Neoplasms, Squamous Cell, pubmed-meshheading:15033673-Stomatitis, pubmed-meshheading:15033673-Survival Analysis, pubmed-meshheading:15033673-Survival Rate, pubmed-meshheading:15033673-Taxoids, pubmed-meshheading:15033673-Thrombocytopenia, pubmed-meshheading:15033673-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
pubmed:affiliation	University Hospital Antwerp, Edegem, Belgium.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I